Literature DB >> 11756457

Histidines 578 and 587 in the S5-S6 linker of the human Ether-a-gogo Related Gene-1 K+ channels confer sensitivity to reactive oxygen species.

Anna Pannaccione1, Pasqualina Castaldo, Eckhard Ficker, Lucio Annunziato, Maurizio Taglialatela.   

Abstract

The K(+) channels encoded by the human Ether-a-gogo Related Gene-1 (hERG1) are crucially involved in controlling heart and brain excitability and are selectively influenced by reactive oxygen species (ROS). To localize the molecular regions involved in ROS-induced modulation of hERG1, segmental exchanges between the ROS-sensitive hERG1 and the ROS-insensitive bovine ether-a-gogo gene (bEAG) K(+) channels were generated, and the sensitivity of these chimeric channels to ROS was studied with the two-microelectrode voltage-clamp technique upon their expression in Xenopus oocytes. Substitution of the S(5)-S(6) linker of hERG1 with the corresponding bEAG region removed channel sensitivity to ROS, whereas the reverse chimeric exchange introduced ROS sensitivity into bEAG. Mutation of each of the two hERG1 histidines at positions 578 and 587 within the S(5)-S(6) linker generated K(+) channels insensitive to modulation by ROS. In addition, the two iron chelators desferrioxamine (1 mm) and o-phenanthroline (0.2 mm) significantly inhibited hERG1 outward K(+) currents and prevented hERG1 inhibition induced by the ROS-scavenging enzyme catalase (1000 units/ml). Finally, the hERG1-inhibitory effect exerted by the iron chelators was prevented by the hERG1 H578D/H587Y double mutation. Collectively, the results obtained suggest that histidines at positions 578 and 587 in the S(5)-S(6) linker region of hERG1 K(+) channels are crucial players in ROS-induced modulation of hERG1 K(+) channels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756457     DOI: 10.1074/jbc.M111353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

2.  Increased serum gamma-glutamyltransferase levels are associated with ventricular instability in type 2 diabetes.

Authors:  Kun Wang; Ling Li; Yang Wu; Yu Yang; Jie Chen; Danyu Zhang; Zhoujun Liu; Juan Xu; Meng Cao; Xiaodong Mao; Chao Liu
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

3.  Cysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels.

Authors:  Katrin Kolbe; Roland Schönherr; Guido Gessner; Nirakar Sahoo; Toshinori Hoshi; Stefan H Heinemann
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

Review 4.  Redox control of cardiac excitability.

Authors:  Nitin T Aggarwal; Jonathan C Makielski
Journal:  Antioxid Redox Signal       Date:  2012-08-16       Impact factor: 8.401

5.  HERG1 currents in native K562 leukemic cells.

Authors:  María S Cavarra; Silvana M del Mónaco; Yanina A Assef; Cristina Ibarra; Basilio A Kotsias
Journal:  J Membr Biol       Date:  2007-09-01       Impact factor: 1.843

Review 6.  Oxidative modulation of voltage-gated potassium channels.

Authors:  Nirakar Sahoo; Toshinori Hoshi; Stefan H Heinemann
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

7.  Functional consequences of methionine oxidation of hERG potassium channels.

Authors:  Zhi Su; James Limberis; Ruth L Martin; Rong Xu; Katrin Kolbe; Stefan H Heinemann; Toshinori Hoshi; Bryan F Cox; Gary A Gintant
Journal:  Biochem Pharmacol       Date:  2007-06-07       Impact factor: 5.858

8.  CO-independent modification of K+ channels by tricarbonyldichlororuthenium(II) dimer (CORM-2).

Authors:  Guido Gessner; Nirakar Sahoo; Sandip M Swain; Gianna Hirth; Roland Schönherr; Ralf Mede; Matthias Westerhausen; Hans Henning Brewitz; Pascal Heimer; Diana Imhof; Toshinori Hoshi; Stefan H Heinemann
Journal:  Eur J Pharmacol       Date:  2017-10-05       Impact factor: 4.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.